Insulet (MEX:PODD) Short Interest


MEX:PODD Insulet Corp MEX:PODD
79 GF Score
Price MXN2,548.13
GF Value MXN6,546.87
Valuation Significantly Undervalued
View Full Analysis

What is Insulet Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:PODD vs MASI, BRKR, GMED: Short Interest Comparison

For the Medical Devices subindustry, Insulet's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Insulet Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Short Interest distribution charts can be found below:

* The bar in red indicates where Insulet's Short Interest falls into.


MEX:PODD
79GF Score
Insulet Corp MEX:PODD
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Insulet (MEX:PODD) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of MXN2,548.13 is trading 61.1% below its estimated GF Value™ of MXN6,546.87. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for MEX:PODD:

  • Short Interest:
  • GF Value™: MXN6,546.87 vs. price of MXN2,548.13 (61.1% below fair value)
  • GF Score™: 79/100

No single metric tells the full story. See the MEX:PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
79GF Score

Get the complete analysis for MEX:PODD

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,548.13
Price
MXN6,546.87
GF Value